Gene Query: CACNA1D

Dataset Description Geneva Score
Tyrosine Kinase Inhibitor Cardiotoxicity 91.89
High-Throughput Screening of Human Induced Pluripotent Stem Cell Cardiomyocytes Predicts Tyrosine Kinase Inhibitor Cardiotoxicity 91.89
Oligogenic inheritance of congenital heart disease involving a NKX2-5 modifier [human] 42.24
Oligogenic inheritance of congenital heart disease involving a NKX2-5 modifier 42.24
Cleavage Factor Im as a key regulator of 3’ UTR length 37.6
Silencing p300 in MCF7 cells to study expression and alternative splicing 34.22
yylncT acts as a gatekeeper of the mesodermal transcriptional program by local modulation of DNMT3B [human_2] 33.94
Estrogen receptor and mTOR signaling rewires cancer metabolism in obesity-associated breast cancer 31.69
Distinct regulation of alternative polyadenylation and gene expression by nuclear poly(A) polymerases 29.12
Presence of NAD+-capped RNA in human cells: function and removal by the DXO deNADing Protein 28.17
BET bromodomain inhibitor iBET151 impedes human ILC2 activation and prevents experimental allergic lung inflammation 26.16
Ultracentifugation and nanoscale deterministic lateral displacement (nanoDLD) of samples for exRNA analysis 24.98
RNA-Seq profiling of iPSC-derived ventricular and atrial cardiomyocytes 23.71
Transcriptome analysis of kidney organoids 23.06
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures [RNA-Seq] 19.55
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures 19.55
The LIN28B/let-7 axis is a novel therapeutic pathway in Multiple Myeloma 17.68
Effects on gene expression of ibrutinib treatment in human stem cells-derived atrial- and ventricular-like cardiomyocytes 17.17
Circular RNAs are super abundant in cervical tumor and plasma detected by high throughput microarray 16.43
Circular RNAs are super abundant in cervical tumor and plasma detected by high throughput microarray [RNA-Seq] 16.43
Evaluation of RNA amplification and RNA-Seq library preparation protocols for spermatozoa RNA profiling 15.96
Transcriptomic analysis of the effect of trastuzumab in human iPSC-CMs 15.4
LncRNA-dependent mechanisms of androgen receptor-regulated gene activation programs [GRO-seq II] 15.01
Single-cell transcriptomics of the human retinal pigment epithelium and choroid in health and macular degeneration 14.4
Human iPSC-derived microglia assume a primary microglia-like state after transplantation into the neonatal mouse brain [Single Cell RNAseq] 13.68
Gene Expression of Breast Cancer Cell Lines Across Biomaterial Platforms 13.33
Function of HNRNPC in breast cancer cells by controlling the dsRNA-induced interferon response 12.73
MULTI-seq: Universal sample multiplexing for single-cell RNA sequencing using lipid-tagged indices 12.54
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells (wtRNA-Seq) 12.46
Polyol pathway links glucose metabolism to the aggressiveness of cancer cells 12.1
Transcriptome analysis of eosinophilic and noneosinophilic chronic rhinosinusitis with nasal polyps reveals distinct lncRNA expression profiles 12.06
RNA polymerase in pre-B-ALL cell lines 11.97
Single-cell analysis of human kidney organoids 11.95
Disease Model of GATA4 Mutation Reveals Transcription Factor Cooperativity in Human Cardiogenesis [RNA-Seq] 11.65
Disease Model of GATA4 Mutation Reveals Transcription Factor Cooperativity in Human Cardiogenesis 11.65
CD86 regulates a pro-survival signal in myeloma cells 11.46
Mutation independent activation of the Notch pathway is associated with Lapatinib resistance in Her2+ breast cancer cell lines 11.33
Low-Cell-Number, Single-Tube Amplification (STA) of RNAs Revealed miRNA Changes from Pluripotency to Endothelium 11.25
Single cell analysis of HSV-1 infection reveals anti-viral and developmental programs are activated in distinct sub-populations with opposite outcomes 11.16
NEUROD1 dependent gene regulation in murine pancreatic endocrine cells and human stem cell derived insulin producing cells 11.12
Rna-seq transcriptome data for insulin-GFP+ cells differentiated from NEUROD1 knock out and NEUROD1+/+ control human embryonic stem cells. 11.12
Derivation of ventrical and atrial cardiomyocytes and maturation using biowires 10.96
Transcriptomic and gene ontology profiling of the human corneal cell types 10.75
LED, a long non-coding RNA activator of enhancer RNAs, is hypermethylated in human cancers 10.74
RNA sequencing of prostate cancers reveal insights on the prognostic significance of visibility on multi-parametric MRI 10.63
Transcriptome analysis of Riociguat and Vehicle control treatment in human hematopoietic stem and progenitor cells 10.62
Gene expression and chromatin organization changes in lamin A/C haploinsufficient human induced pluripotent stem cell-derived cardiomyocytes 10.58
Gene expression and chromatin organization changes in lamin A/C haploinsufficient human induced pluripotent stem cell-derived cardiomyocytes [RNA-seq] 10.58
A novel CRISPR-engineered prostate cancer cell line defines the AR-V transcriptome and identifies PARP inhibitor sensitivities. 10.49
Targeted inhibition of STAT/TET1 axis as a potent therapeutic strategy for acute myeloid leukemia 10.17
Evaluation of the immunogenicity of live-attenuated influenza vaccines in nasal epithelial cells in primary differentiated human nasal epithelial cells [RNA-Seq] 10.17
Evaluation of the immunogenicity of live-attenuated influenza vaccines in nasal epithelial cells in primary differentiated human nasal epithelial cells 10.17
SHP2 Drives Adaptive Resistance to ERK Signaling Inhibition in Molecularly Defined Subsets of ERK-dependent Tumors 9.99
Apoptotic endothelial cells release small extracellular vesicles loaded with immunostimulatory viral-like RNAs 9.97
RNA-seq profiling of the human neutrophil genome during PMA- and E. coli encounter-induced activation 9.9
Human neutrophil genome during PMA- and E. coli encounter-induced activation 9.9
Diverse AR-V7 cistromes in castration-resistant prostate cancer are governed by HoxB13 9.87
Single Cell RNASeq profiling of stromal vascular fraction from Subcutaneous and visceral adipose tissue 9.57
Impact of Escherichia coli K12 and O18 on human platelets: effects on platelet activation, spliced platelet RNAs and proteins 9.54
Genome-wide CRISPR-Cas9 screen identifies druggable synthetic lethality between LSD1 and MTORC1 in MLL-translocated AML 9.45
RNA-seq analysis of melanoma and carcinoma cells expressing FOXQ1 9.37
Genome-wide analysis of STAT3 in diffuse large B-cell lymphoma 9.28
Estrogen Receptor Beta Impacts Hormone-Induced Alternative mRNA Splicing in Breast Cancer Cells 9.22
LncRNA-dependent mechanisms of androgen receptor-regulated gene activation programs 9.15
Characterization of macrophage - cancer cell crosstalk in estrogen receptor positive and triple-negative breast cancer 9.13
Comparing oestrogen-responsive genes in endometrial and breast cancer cell lines 9.0
Distinct Pathological Signatures in Human Cellular Models of Myotonic Dystrophy Subtypes 8.85
Comprehensive comparative analysis of RNA sequencing methods for degraded or low input samples 8.74
Non-IG Aberrations of FOXP1 in B-Cell Malignancies Lead to an Aberrant Expression of N-Truncated Isoforms of FOXP1 8.69
Genistein and bisphenol A exposure cause estrogen receptor 1 to bind thousands of binding sites in a cell type-specific manner 8.57
Transcriptomic responses to Ivacaftor and prediction of Ivacaftor clinical responsiveness 8.4
Defective transcription elongation in a subset of cancers confers immunotherapy resistance (human cell lines RNA-Seq) 8.22
A peninsular structure coordinates asynchronous differentiation with morphogenesis to generate pancreatic islets [bulk vs buds] 8.16
Mapping of DHT-responsive or -independent AR-binding sites induced by activated Src in prostate cancer cell lines [RNA-seq] 8.12
Mapping of DHT-responsive or -independent AR-binding sites induced by activated Src in prostate cancer cell lines 8.12
Regulators of cellular heterogeneity in basal-like breast cancer influence symmetric versus asymmetric division rates (shRNA targeting) 8.09
Comparative analysis of kidney organoid and adult human kidney single cell and single nucleus transcriptomes 8.05
Epigenomic plasticity enables human pancreatic alpha to beta cell reprogramming 8.03
TT-Seq captures the human transient transcriptome 8.01
HEK293 Heat-shock experiment 7.83
Epigenetic reprogramming at estrogen-receptor binding sites alters the 3D chromatin landscape in endocrine resistant breast cancer [RNA-seq] 7.75
Epigenetic reprogramming at estrogen-receptor binding sites alters 3D chromatin landscape in endocrine resistant breast cancer 7.75
Whole Transcriptomic Sequencing of Metastatic Castration Resistant Prostate Cancer Samples 7.7
High-throughput RNA sequencing on circular RNA profiles of human bladder cancer tissues and normal bladder tissues 7.47
CENPA-Bound Genes and Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cells 7.46
Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cell Lines 7.46
Reassessment of Exosome Composition 7.14
HIV-1 perturbs homeostatic ILCs, unmasks ILC1 plasticity, and boosts TCF7+ memory NK cells 7.14
BCL6 confers KRAS-mutant NSCLCs resistance to BET inhibitors 7.02
Entrectinib Resistance in a Neuroblastoma Xenograft Model 6.97
Transcriptomic characterization of a human in vitro model of arrhythmogenic cardiomyopathy under topological and mechanical stimuli 6.95
Circular RNAs in the mammalian brain are highly abundant, conserved, and dynamically expressed 6.85
Human islets of varying quality: the good, the (not so) bad and the ugly 6.84
GRHL2 is a key lineage determining factor which collaborates with FOXA1 to establish a targetable collateral pathway in the setting of endocrine therapy-resistant breast cancer (RNA-Seq data set 1) 6.78
Characterization of human mosaic Rett syndrome brain tissue by single-nucleus RNA sequencing (Total RNA sequencing) 6.78
Genes regulated by soluble guanylyl cyclase in VCaP prostate cancer cells 6.71
Induction and Therapeutic Targeting of Human NPM1c+ Myeloid Leukemia in the Presence of Autologous Immune System in Mice 6.68
Transciptomic profiling of human fetal lung samples 6.48
Large-scale epigenetic reprogramming is punctuated late during the evolution of pancreatic cancer progression [RNA-Seq] 6.45
Endometrial transcriptome and PGR cistrome in cycling fertile women [RNA-seq] 6.39
Endometrial transcriptome and PGR cistrome in cycling fertile women 6.39
Functional Importance of eRNAs for Estrogen-dependent Gene Transcriptional Activation 6.35
Improving fibroblast characterization using single-cell RNA sequencing: an optimized tissue disaggregation and data processing pipeline 6.28
The evolution of N6-methyladenosine in primates 6.26
Circular RNAs are down-regulated in KRAS mutant colon cancer cells and can be transferred to exosomes 6.22
Insights into snoRNA biogenesis and processing from PAR-CLIP of snoRNA core proteins and small RNA sequencing 6.18
Effect of circPTPRM on the biological behaviors of hepatocellular carcinoma cells in vitro and its clinical significance. 6.06
NET-CAGE Characterizes the Dynamics and Topology of Human Transcribed Cis-regulatory Elements 5.92
BET bromodomain inhibition 5.84
Effect of BET bromodomain inhibition with JQ1 in stressed human derived iPS cardiomyocytes 5.84
Prolyl hydroxylation regulates protein degradation, synthesis, and splicing in human induced pluripotent stem cell-derived cardiomyocytes 5.81
Gene expression in mature and immature human ES-derived beta cells, and sorted beta-cells from adult islets 5.76
Gene expression in PANC1 cells treated with Rakicidin 5.74
Transcriptomic analysis of inter- and intra-patient variation in human iPSC cardiomyocytes: Platform for precision medicine to predict drug toxicity 5.72
Analysis of active enhancers and direct androgen receptor target genes in VCaP prostate cancer cells 5.6
Brain organoids reproducibly generate the cellular diversity of the human cerebral cortex 5.54
RNA-seq melanoma 5.44
Polycomb complexes associate with enhancers to promote oncogenic transcriptional programs in cancer 5.31
Persistence of stem cell metabolism in cancers as a failure of differentiation 5.3
High-throughput RNA sequencing on circular RNA profiles of human pancreatic cancer cell lines and gemcitabine resistant pancreatic cancer cell lines. 5.27
PTHrP overexpression in MCF7 cells 5.24
TOP2B disturbed the quality of human oocytes with advanced maternal age 5.21
The age and genomic integrity of neurons after cortical stroke in humans 5.05
Molecular mechanism underlying increased ischemic damage in the ALDH2*2 genetic polymorphism using a human iPSC model system 5.05
3D genome of multiple myeloma reveals spatial genome disorganization associated with copy number variations 5.04
Short and long-term effects of CDK4/6 inhibition on early stage breast cancer 5.01
Compared performance of Affymetrix HTA arrays and Illumina RNAseq for the analysis of tumours 4.94
Compared performance of Affymetrix HTA arrays and Illumina RNAseq for the analysis of tumours [RNA-seq] 4.94
Defective transcription elongation in a subset of cancers confers immunotherapy resistance 4.92
Stably-paused genes revealed through inhibition of transcription initiation by the TFIIH inhibitor Triptolide 4.88
Epigenetic modulation of β-cells by interferon-α via PNPT11-miR-26a-TET2 triggers autoimmune diabetes [RNA-seq] 4.84
Epigenetic modulation of β-cells by interferon-α via PNPT11-miR-26a-TET2 triggers autoimmune diabetes 4.84
RNA-Seq analysis of NKX2.2 knockdown in human pancreatic islets 4.8
NKX2.2 4.8
The Wnt/β-catenin-signaling pathway is modulated by androgen ablation therapy for advanced clinical prostate cancer and contributes to androgen independent cell growth 4.79
RNA-sequencing in irradiated and normal A549 cells. 4.73
Effects of Cardiac Glycosides on RNA Expression in Prostate Cancer LNCaP-abl Cells 4.71
Neuronal deletion of Gtf2i, associated with Williams syndrome, causes behavioural and myelin alterations rescuable by a remyelinating drug [human] 4.68
Neuronal deletion of Gtf2i, associated with Williams syndrome, causes behavioural and myelin alterations rescuable by a remyelinating drug 4.68
Neuronal brain region-specific DNA methylation and chromatin accessibility are associated with neuropsychiatric trait heritability 4.61
Neuronal brain region-specific DNA methylation and chromatin accessibility are associated with neuropsychiatric trait heritability [RNA-Seq] 4.61
Identification of metabolically distinct adipocyte progenitor cells in human adipose tissues 4.52
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes [RNA-Seq] 4.34
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes 4.34
The human blood-nerve barrier transcriptome 4.33
Transcriptome analysis in HT29 and SW480 cells depleted of Prdx2 4.25
RNA-seq of Single-Cell Genotyping of Transcriptomes 4.24
Single-Cell Genotyping of Transcriptomes 4.24
Next Generation Sequencing Analysis of Colorectal Cancer Tissue Transcriptomes 4.21
SNHG5 siRNA knock down in HCT116 cells 4.2
Total RNA-Seq data from leukemic patients with complex structural variants 4.2
Biomarkers of Cavernous Angioma with Symptomatic Hemorrhage (CASH) 4.18
Biomarkers of Cavernous Angioma with Symptomatic Hemorrhage (CASH) [RNA-seq] 4.18
Measure transcript integrity using RNA-seq data 4.17
Patient Derived Xenograft for Delivery of Precision Medicine in Castrate Resistant Prostate Cancer 4.12
SREBP1 drives Keratin 80-dependent cytoskeletal changes and invasive behavior in endocrine resistant ERα breast cancer 4.11
Pan-cancer transcriptomic analysis associates long non-coding RNAs with key mutational driver events 4.11
Next Generation Sequencing Facilitates Quantitative Analysis of SW480 cells and HPSE-knockdown SW480 cells Transcriptomes 4.09
Transcriptomics profiling of Alzheimer’s disease reveal novel molecular targets 4.06
Reconstituting development of pancreatic intraepithelial neoplasia from primary human pancreas duct cells 4.04
Ascorbate Suppresses VEGF Expression in Retinal Pigment Epithelial Cells 4.04
The chromatin modifier CHD8 targets autism risk genes during human neurodevelopment  4.02
H3.3K27M cooperates with p53 loss and Pdgfra gain in mouse embryonic neural progenitor cells to induce invasive high-grade gliomas [Human RNA-Seq] 3.98
H3.3K27M cooperates with p53 loss and Pdgfra gain in mouse embryonic neural progenitor cells to induce invasive high-grade gliomas 3.98
Differential expression of pancreatic cancer PANC1 cells treated with pilocarpine 3.98
Transcriptomic analysis of healthy donor and Sickle Cell Disease (SCD) hematopoietic stem/progenitor cells 3.91
Gene target specificity of the Super Elongation Complex (SEC) family: How HIV-1 Tat employs selected SEC members to activate viral transcription 3.9
Hematopoietic Stem and Progenitor Cells from Human Pluripotent Stem Cells via Transcription Factor Conversion of Hemogenic Endothelium 3.89
Effects of plasticizers (bisphenol A, bisphenol AF) and an herbicide in MCF7 human breast cancer cells 3.88
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq SS] 3.86
Global loss of epigenetic and transcriptional fidility defines a subclass of cancer with immunotherapy resistance 3.83
Single-cell RNA-seq reveals novel cell differentiation dynamics during human airway epithelium regeneration 3.83
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 1: RNA-seq) 3.82
Intrinsic histone acetyltransferase activity of BRD4 is responsible for nucleosome eviction and transcriptional activation 3.81
Genome wide transcript and miRNAanalysis of invitro and in-vivo generated human cardiac samples 3.79
Nuclear HNRNPA2B1 HITS-CLIP and RNA-seq 3.77
In vitro modeling of human germ cell development using pluripotent stem cells 3.76
The Dynamic Epigenetic Landscape of the Retina During Development, Reprogramming, and Tumorigenesis [RNA-Seq_Hs] 3.74
The Dynamic Epigenetic Landscape of the Retina During Development, Reprogramming, and Tumorigenesis 3.74
JQ1 +/- Vemurafenib in BRAF mutant melanoma (A375) 3.68
The effects of U1 snRNA mutation in chronic lymphocytic leukemia cell lines 3.64
Transcriptomic profiling of O-GlcNAcylated mRNA-protein complexes by using OG-CLAP in HeLa cells. 3.62
Conserved roles for murine mDUX and human DUX4 in activating cleavage stage genes and MERVL/HERVL retrotransposons [RNA-Seq] 3.59
Genome-Wide Transcriptional Effects of the Anti-Cancer Agent Camptothecin 3.57
ChIP-seq of ER and RUNX2 in MCF7 breast cancer cell lines 3.55
quanTIseq: quantifying immune contexture of human tumors 3.54
Tracing the temporal-spatial transcriptomic landscapes of the human fetal digestive tract by single cell RNA-seq analysis [adult tissues] 3.53
Muscleblind-like 1 suppresses breast cancer metastatic colonization and stabilizes metastasis suppressor transcripts 3.49
MBNL1-dependent modulation of gene expression in MDA-MB-231 breast cancer cells 3.49
Epigenetic programming during monocyte to macrophage differentiation and trained innate immunity 3.46
Total RNAseq of human putamen and caudate nucleus tissues in healthy control and Bipolar Disorder individuals 3.43
RNA-seq of overgrown interscapular adipose tissue with biallelic MFN2 mutations 3.42
TALEN-based knockout of mir-141 and mir-200c in SK-BR-3 cells 3.41
RNA-seq of SOX5 overexpressing primary human neuronal progenitors 3.36
RNA-seq and m6A-seq of AML cells with FTO knockdown or inhibition 3.36
Analyzing the interactions of mRNAs, miRNAs, lncRNAs and circRNAs to predict competing endogenous RNA networks in glioblastoma 3.35
mRNA expression profile of A549 cells and MSR-A549 cells with or without JQ1 treatment 3.32
A549 cells and MSR-A549 cells 3.32
A cell-permeable stapled peptide inhibitor of the estrogen receptor/coactivator interaction 3.3
mRNA and RNC-mRNA deep sequencing of three hepatocellular carcinoma cell lines 3.28
Expression profiles of the four human major ectodermal lineages 3.27
Total RNA-seq in ALL-SIL upon TLX1 knockdown 3.17
Potent and targeted activation of HIV-1 using the CRISPR/Cas9 activator Complex 3.17
RNA sequencing, chromatin accesibility and ChIP seq analysis of BAP1 -/- human liver organoids 3.1
Aortic Valve Tissue: Stenosis vs. Sclerosis 3.08
RNA-seq data of small cell carcinoma of the bladder (SCCB) /urothelial carcinoma (Non-SCCB) clinical samples, and bladder-PARCB cell lines 3.05
RNA Sequencing of three pairs of gastric cancer 3.03
Global gene expression profiles of cardiomyocytes differentiated from human pluripotent stem cells (hiPSC-CMs) in 3D culture exposed to ethanol 2.99
Temporal dynamic reorganization of 3D chromatin in hormone-induced breast cancer and endocrine resistance 2.98
Effect of estrogen (E2) treatment on the C4-12 relative to the MCF7 cells 2.92
Tracing transcriptome profiles of human oocyte cultured by growth hormone or not in vitro by single cell RNA-seq 2.89
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming 2.86
Methylome, hydroxymethylome, and integrative transcriptome profiling in human CRC tissue and paired normal tissues 2.85
Programmable RNA N6-methyladenosine editing by CRISPR-Cas9 conjugates 2.85
Radiation enhances melanoma response to immunotherapeutic and synergizes with benzodiazepines to promote improved anti-tumor activity 2.84
Comprehensive Transcriptome Analysis of Cerebral Cavernous Malformation Across Multiple Species and Genotypes 2.83
Treatment of SW480 colon cancer cell induced xenografts with AZD and DBZ 2.76
T47D RNA-seq and ChrRNA-seq data 2.74
Arginine citrullination at the C-terminal domain controls RNA Polymerase II transcription 2.74
NSD2 overexpression links drives clustered chromatin and transcriptional changes in a subset of insulated domains of insulated domains 2.73
Tyrosine-1 of RNAPII CTD controls global termination of gene transcription in mammals 2.72
Induction of human regulatory innate lymphoid cells from group 2 innate lymphoid cells by retinoic acid 2.71
Single-cell Transcriptomic Atlas of the Human Retina Identifies Cell Types Associated with Age-Related Macular Degeneration 2.67
Identification of Atrial Fibrillation associated genes and functional non-coding variants 2.67
Uridylation-mediated RNA quality control pathway in mammalian cytoplasm [RNA-Seq] 2.67
TUT-DIS3L2 is a mammalian surveillance pathway for aberrant structured non-coding RNAs. 2.67
hiPSCs unravel aberrant TGFβ signaling as an etiology of left ventricular non-compaction 2.63
Direct Isolation and Characterization of Human Nephron Progenitors. 2.6
RNA Seq analysis of NKX2-5 Null and Het human embryonic stem cells in cardiomyogenesis 2.6
Combined Experimental and System-Level Analyses Reveal the Complex Regulatory Network of miR-124 during Human Neurogenesis [d7+d14] 2.59
High-throughput single cell transcriptome analysis and CRISPR screen identify key β cell-specific disease genes 2.58
RNA-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 2.58
RNA-sequencing and MeDIP-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 2.58
Molecular analysis of renal cell carcinoma with unclassfied histology [gene expression] 2.56
Molecular analysis of renal cell carcinoma with unclassfied histology 2.56
Platelet Transcriptome Profiling in HIV and ABCC4 as a Biomarker of Platelet Activity 2.52
Differential effects of estrogen receptor beta isoforms on glioblastoma progression 2.52
Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors 2.51
Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors [RNA-seq] 2.51
Fixed tissue ChIP-Seq (FiT-Seq) of archived clinical samples reveals chromatin dynamics and tumor-specific enhancer profiles 2.51
CHD1 loss sensitizes prostate cancer to DNA damaging therapy by promoting error-prone double-strand break repair 2.47
IGF2BP3 controls cancer cell invasiveness by modulation RISC function 2.46
Global gene expression profiles of cardiac progenitors differentiated from human pluripotent stem cells in 3D culture under simulated microgravity 2.44
Mutant p63 disrupts the key specification switch from the multipotent cell state to stratified epithelia during epithelial differentiation/in ectodermal dysplasia disorders 2.43
Pseudotime Ordering of Single Human Beta-Cells Reveals States of Insulin Production and Unfolded Protein Response 2.42
Controlling for gene expression changes in transcription factor protein networks. 2.42
Expression profiling of lncRNAs, miRNAs and mRNAs and their differential expression in leiomyoma using next generation RNA sequencing 2.41
Exploring ILF2 regulatory genes by next-generation sequencing 2.38
HEXIM1 is induced by DHODH inhibition to suppress melanoma [Gro-Seq] 2.38
HEXIM1 is induced by DHODH inhibition to suppress melanoma 2.38
Expression profiling by high throughput sequencing of tumors derived from human prostate epithelial cells transformed with the oncogenes N-Myc and myrAKT1. 2.36
Differentially Expressed Genes for Atrial Fibrillation Identified using RNA Sequencing from Paired Human Left and Right Atrial Appendages. 2.34
Immunophenotyping and Transcriptomic Outcomes in PDX-Derived TNBC Tissue 2.28
RNA-Seq of the corpus callosum from 12 individuals 2.27
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo [RNA-seq] 2.26
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo 2.26
Modeling the MYC-driven normal-to-tumour switch in breast cancer. 2.25
Deciphering H3K4me3 Broad Domains Associated With Gene Regulatory Networks and Conserved Epigenomic Landscapes in the Human Brain [RNA-Seq] 2.23
Deciphering H3K4me3 Broad Domains Associated With Gene Regulatory Networks and Conserved Epigenomic Landscapes in the Human Brain 2.23
High-throughput sequencing of the human hepatic progenitor cell niche in PSC and HCV. 2.22
Single-cell Transcriptomics reveals multi-step adaptations to endocrine therapy 2.21
Transcriptome analyses of human pancreatic islets and pseudoislets 2.17
Genome-wide detection of DNase I hypersensitive sites in single cells and FFPE tissue samples 2.15
RNA-seq of exosomes identifies lncRNA profiles that distinguish early-stage esophageal squamous cell carcinoma (ESCC) from non-malignant esophagitis 2.13
Global unleashing of transcription elongation waves in response to genotoxic stress restricts somatic mutation rate 2.12
Transcriptomes change differerntly in differernt cancer cells upon EPZ-6438 treatment 2.1
RNA-Seq analysis of human neutrophils isolated by different protocols (Polymorphprep and negative selection) and incubated with and without in vitro cytokine stimulation 2.1
Genome-Wide Specificity of DNA-Binding, Gene Regulation, and Chromatin Remodeling by TALE- and CRISPR/Cas9-Based Transcription Factors 2.1
Coordinated regulation of synthesis and stability of RNA during the acute TNF-induced proinflammatory response 2.1
SnapShot-Seq: a method for extracting genome-wide, in vivo mRNA dynamics from a single total RNA sample 2.09
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 2: scRNA-seq) 2.06
Genome-wide maps of H3K36me3 in ccRCC and RNA-seq of matched nephrectomy samples 2.04
RNA sequencing of matched nephrectomy samples [RNA-seq] 2.04
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex (Gro-seq) 2.04
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex 2.04
Genome-wide RNA-sequencing of human islets 48 hour after transduction with adenoviruses expressing either GFP (control), or histone chaperone ASF1B. 2.02
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer [RNA-seq] 2.0
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer 2.0
Transcriptomic profiling of sequential tumours from breast cancer patients provides a global view of metastatic expression changes following endocrine therapy 2.0
Comparing effects of perfusion and hydrostatic pressure on human chondrocytes using gene profiles 2.0
Patient-derived xenograft platform for metastatic melanoma: a model for studying resistance to targeted therapy. 1.98
The expression profiles of GBC liver metastasis 1.94
Global Long Terminal Repeat activation participates in establishing the unique gene expression program of classical Hodgkin Lymphoma [RNA-Seq] 1.93
N6-methyladenosine (m6A) profiling of EndoC-bH1 cell line and RNA seq of Mettl14 knockout mice beta cell 1.93
Cellular recruitment by podocyte-derived pro-migratory factors in assembly of the human renal filter 1.93
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia [scRNA-seq] 1.92
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia 1.92
Gene expression by high-throughput sequencing of T47D-MTVL human breast cancer cells upon H1.4 knock-down and multiple H1 variants 1.88
Wide-scale analysis of alternative polyadenylation (APA) associated with proliferation and transformation using 3'-Seq 1.84
CD13 and ROR2 permit isolation of highly enriched cardiac mesoderm from differentiating human embryonic stem cells 1.83
Isolation of highly enriched cardiac mesoderm from differentiating human embryonic stem cells 1.83
RNA Missplicing in Fuchs Endothelial Corneal Dystrophy 1.81
Effect of selective glucocorticoid receptor modulation (SGRM) on gene expression in human prostate cancer cell lines 1.79
METTL3 and WTAP 1.76
Expression profile of GIST48 cells with siETV1 or siFOXF1 knockdown 1.76
FOXF1 defines the core-regulatory circuitry in gastrointestinal stromal tumor (GIST) 1.76
Microglia innatly develop within cerebral organoids 1.76
Acriflavine inhibits the epithelial-to-mesenchymal transition in vitro in liver and pancreatic cancer cells (part of study on PANC1 cells treated with CoCl2) 1.76
A SRp55-regulated alternative splicing network controls pancreatic beta cell survival and function 1.73
Gene expression alterations of pancreatic intraepithlial neoplasia 1.71
RNA-sequencing 1.69
Comparison of small cell lung cancer PDX model FHSC04 for response to LSD1 inhibitor RG6016/ORY1001 1.69
Loss of endometrial plasticity in recurrent pregnancy loss 1.68
Loss of endometrial plasticity in recurrent pregnancy loss (RNA-Seq) 1.68
Different Temporal Effects of Ebola Virus VP35 and VP24 Proteins on Global Gene Expression in Human Dendritic Cells 1.67
RNA m5C Methylation in breast cancer using MeRIP-Seq 1.66
Identification of miRNA signatures during the differentiation of hESCs into retinal pigment epithelial cells 1.66
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer [RNA-Seq] 1.65
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer 1.65
PolyA+ RNA-seq in ALL-SIL upon TLX1 knockdown 1.64
Disruption of the TFAP2A regulatory domain causes Branchio-Oculo-Facial Syndrome (BOFS) and illuminates pathomechanisms for other human neurocristopathies 1.63
A Distinct Epigenetic Program Underlies the 1;7 Translocation in Myelodysplastic Syndromes (MDS) 1.63
Expression Analysis of dic(1;7)(q10;p10) in Myelodysplastic Syndromes (MDS) compared to control cohort and therapy-related Myeloid Neoplasms (t-MN) 1.63
Gene expression profiling of human iPS cell-derived podocytes and sorted human adult podocytes 1.63
Age-Related Gene Expression Changes in Prostate Cancer Patients 1.62
Age-Related Gene Expression Changes in Prostate Cancer Patients [RNA-Seq] 1.62
TT-seq captures simultaneous activation of eRNAs and promoters during T cell activation 1.6
Genetic and Epigenetic Landscapes of Laterally Spreading Tumors of the Colorectum 1.59
snRNAs as regulators of alternative splicing 1.57
Definition of Natural Killer cell heterogeneity in humans and mice by high-throughput single-cell RNA sequencing 1.51
Stapled peptide inhibitors of RAB25 target context-specific phenotypes in cancer 1.51
Distinct structural classes of activating FOXA1 alterations in prostate cancer progression [RNA-Seq] 1.5
Distinct structural classes of activating FOXA1 alterations in prostate cancer progression 1.5
CD95/Fas ligand mRNA is toxic to cells 1.5
Epigenetic changes induced by Bacteroides fragilis toxin (BFT) 1.5
Epigenetic changes induced by Bacteroides fragilis toxin (BFT) [RNA-seq] 1.5
RNA-dependent RNA polymerase sequence specificities of capsnatching viruses are tailored to aid viral replication 1.47
Somatic cell fusions reveal extensive heterogeneity in basal-like breast cancer 1.47
Somatic cell fusions reveal extensive heterogeneity in basal-like breast cancer [RNA-Seq] 1.47
Molecular Hallmarks of Experimentally Acquired Immunity to Malaria [Pilot Study] 1.46
Transcriptome of EBV-infected gastric cancer cell lines 1.46
miR-155 plays a crucial role in ALS and is an immune therapeutic target [RNA-Seq] 1.45
Targeting miR-155 restores abnormal microglia and attenuates disease in SOD1 mice 1.45
Transcriptome landscape of HeLa response upon triamcinolone acetonide 1.44
Common inflammatory pathways between NEC and Crohn's disease 1.43
Gene expression profiling in metabolically heterogeneous human lung tumors 1.43
Integrative Genomic and Transcriptomic Analysis Identified Candidate Genes Implicated in the Pathogenesis of Hepatosplenic T-cell Lymphoma 1.43
Hepatosplenic T cell lymphoma 1.43
Comprehensive RNA sequencing of healthy human endometrium at two time points of the menstrual cycle 1.41
Integrative analysis of microRNAs and mRNAs in liver tissue and exosomes from blood of hepatitis C virus (HCV) related hepatocellular carcinoma (HCC) patient to identify biomarker and regulators of HCC 1.38
Integrative analysis of microRNAs and mRNAs in liver tissue and exosomes from blood of hepatitis C virus (HCV) related hepatocellular carcinoma (HCC) patient to identify biomarker and regulators of HCC [Total RNA-Seq] 1.38
Gene expression profiles of rescue with wild type or SUMO double mutant TRIM24 1.37
Transcriptome response to 4h IL-1b stimulation of primary chondrocytes 1.37
Dynamic reorganization of nuclear architecture during human cardiogenesis 1.36
Dynamic reorganization of nuclear architecture during human cardiogenesis [RNA-seq] 1.36
The role of CFTR in islet function 1.35
Transcriptome analysis in a radiosensitive and a radioresistant cell line after ionizing radiation 1.35
mRNA profiling reveals determinants of trastuzumab efficiency in HER2-positive breast cancer 1.28
An interaction with Ewing's sarcoma breakpoint protein EWS defines the specific oncogenic mechanism of ETS factors rearranged in prostate cancer 1.28
Next Generation Sequencing Study of Circadian Changes in Transcriptome of Human Pineal Gland 1.27
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis[Ribosome Profiling] 1.26
Defining the Transcriptional Landscape during Cytomegalovirus Latency with Single-Cell RNA Sequencing 1.23
Determining effects of microbial metabolite, Urolithin A on colon epithelial cells 1.22
Time-dependent regulation of cellular programming of monocytes by NCOR2 [RNASeq_KD] 1.21
Identification of a LIF-responsive replication-competent human β cell 1.2
RNA-Sequencing of human dermal lymphatic endothelial cells (HDLEC) treated with siRNA targeting YAP/TAZ and YAP5SA 1.19
Poly(A)-ClickSeq resolves CF25-mediated alternative poly-adenylation, HeLa 1.18
Structural basis for human respiratory syncytial virus NS1-mediated modulation of host responses 1.17
Transcriptome analysis revealed impaired cAMP responsiveness in PHF21A-deficient human cells 1.17
RNA sequencing of Formalin-Fixed, Paraffin-Embedded Specimens for Gene Expression Quantification and Data Mining 1.15
ML29755 RNA-seq data 1.15
A monocyte gene expression signature in the early clinical course of Parkinson’s disease 1.13
IL-21/type I interferon interplay regulates neutrophil-dependent innate immune responses to Staphylococcus aureus 1.13
Transcriptome analysis of fetal Klinefelter testis tissue samples compared to controls 1.12
Integration of ATAC-seq and RNA-seq Identifies Human Alpha Cell and Beta Cell Signature Genes 1.12
RNA-sequencing of the brain transcriptome implicates dysregulation of neuroplasticity, circadian rhythms, and GTPase binding in bipolar disorder 1.11
The landscape of alternative splicing in aggressive prostate cancers 1.1
Transcriptomic profile of intestinal epithelial cells obtained from ileal endoscopic biopsies from newly-diagnosed, pediatric Crohn's disease patients and healthy controls. 1.08
The Wnt/β-catenin and RAS-ERK Pathways were Activated in Tissues of Chemotherapy-Resistant Gastric Cancer PDX Tumor 1.05
Interferon receptor signaling pathways regulating PD-L1 and PD-L2 expression 1.04
Neonatal and adult human testis defined at the single-cell level 1.03
RNA-seq in endometrial stromal tumors 1.03
Next generation sequencing of advanced non-castrate prostate cancer treated with docetaxel chemotherapy 1.01
Transcriptome profiling of hnRNP A2/B1 and A1 depleted cells 0.98
Characterization of human mosaic Rett syndrome brain tissue by single-nucleus RNA sequencing 0.98
RNA-Seq analysis and comparison of corneal epithelium in keratoconus and myopia patients 0.97
Dissecting cell composition and cell-cell interaction network of human disease heart tissue by single-cell sequencing 0.94
Regulation of cellular heterogeneity and rates of symmetric and asymmetric divisions in triple-negative breast cancer 0.93
Next generation sequencing of small RNAs isolated from exosomes in human semen 0.93
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells 0.93
Neuronal Development And The Onset Of Electrical Activity In The Human Enteric Nervous System 0.92
Genome-wide mapping of TEL-AML1 targets in acute leukemia 0.92
Identification and validation of differentially expressed transcripts by RNA-Sequencing of formalin-fixed, paraffin-embedded (FFPE) lung tissue from patients with Idiopathic Pulmonary Fibrosis 0.92
Fra-1 is a key driver of colon cancer metastasis and a Fra-1 classifier predicts disease-free survival 0.88
mRNA-Seq profiling SIX2+ and Foxd1+ cells in mouse embryonic and SIX2+ and SIX2-/MEIS1+ cells human fetal kidney 0.83
Reprogramming of Tumor-infiltrating Immune Cells in Early Stage of NSCLC 0.83
Reducing the structure bias of RNA-Seq reveals a large number of non-annotated non-coding RNA 0.82
A non-canonical role of YAP/TEAD is required for activation of estrogen-regulated enhancers in breast cancer [RNA-seq] 0.82
A non-canonical role of YAP/TEAD is required for activation of estrogen-regulated enhancers in breast cancer 0.82
RNAseq analysis of ruxolitinib treated breast cancers 0.82
Transcriptomic profiling of cleavage-resistant RIPK1 induced autoinflammation syndrome patients 0.8
Transcriptomics analysis of enteroendocrine cells following vertical sleeve gastrectomy 0.79
Transcriptomics analysis of human jejunal enteroendocrine cells after vertical sleeve gastrectomy 0.79
Low-dose decitabine priming endows CAR T cells with enhanced and persistent anti-tumor potential by epigenetic reprogramming 0.77
Transcriptome sequencing reveals aberrant alternative splicing in Huntington's disease 0.76
Innate-like activation of mucosal-associated invariant T cells in mycobacterial infection 0.75
Gene expression profiles of 4-1BB+PD-1-high, 4-1BB-PD-1-high, and PD-1-int tumor-infiltrating CD8 T cells in hepatocellular carcinoma 0.74
mRNA sequencing of highly and lowly metastatic human colorectal cancer PDXs 0.73
Recurrent alterations of TNFAIP3 (A20) in T-cell large granular lymphocytic leukemia 0.7
Single-Cell Transcriptome Analysis of Lineage Diversity and Microenvironment in High-Grade Glioma 0.7
Identification of grade and origin specific cell populations in serous epithelial ovarian cancer by single cell RNA-seq 0.69
Comprehensive analysis of microRNA expression in regionalized human neural progenitor cells reveals microRNA-10 as a caudalizing factor 0.68
CDK12 regulates alternative last exon mRNA splicing and promotes invasion of a breast cancer cell line 0.68
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation 0.67
T-bet recruits P-TEFb to super-enhancers to regulate T helper cell differentiation (RNA-Seq) 0.67
T-bet recruits P-TEFb to super-enhancers to regulate T helper cell differentiation 0.67
A single-cell transcriptome atlas of the human pancreas 0.66
Rate of elongation by RNA polymerase II is influenced by specific gene features and histone modifications 0.66
Aberrant expression profile of lncRNA and mRNA in dilated cardiomyopathy by RNA-sequence 0.65
Stretch-Enhancers Delineate Disease-Associated Regulatory Nodes in T Cells 0.64
Targets of CDK12 on ZR-75-30 breast cancer cells (RNA-seq) 0.64
Molecular Biomarkers Screened by Next-generation RNA Sequencing for non-sentinel lymph node status predicting in breast cancer patients with metastatic sentinel lymph node 0.63
Inhibition of ERG Activity in Patient Derived Prostate Cancer Xenografts using the Small Molecule Inhibitor YK-4-279 0.62
PANCR, the PITX2 adjacent noncoding RNA, is specifically expressed in human left atria and regulates PITX2c expression 0.59
Recurrent somatic mutations in POLR2A define a distinct subset of meningiomas [RNA-seq] 0.59
Recurrent somatic mutations in POLR2A define a distinct subset of meningiomas 0.59
RNA profiling Analysis of the Serum Exosomes Derived from Active and Latent M.tuberculosis infectious Patients 0.56
Three congruent human Schwann cell models of CMT1A reveal a converged phenotype 0.55
CRISPR-mediated deletion of prostate cancer risk-associated CTCF loop anchors identifies repressive chromatin loops 0.55
The serine hydroxymethyltransferase-2 (SHMT2) initiates lymphoma development through epigenetic tumor suppressor silencing. 0.54
Gene expression profiling in follicular lymphoma (FL) samples and paired transformed follicular lymphoma (tFL) (n=6 samples) 0.54
Illumina HiSeq Sequencing on Breast cancer PDX samples 0.53
Compare of gene expression between p16INK4A positive and negative regions of colon cancer from five patients 0.51
Single-cell RNA Sequencing Resolves Spatiotemporal Development of Pre-thymic Lymphoid Progenitors and Thymus Organogenesis in Human Embryos 0.5
Peptidomimetic blockade of MYB in acute myeloid leukemia [RNA-seq] 0.5
Peptidomimetic blockade of MYB in acute myeloid leukemia 0.5
Non-inflammatory tumor microenvironment of Diffuse Intrinsic Pontine Glioma (DIPG) 0.49
Gene expression profiling of patient's DCIS-IDC tandem lesions by RNA sequencing analysis 0.46
Profiling premalignant lesions in lung squamous cell carcinomas identifies mechanisms involved in stepwise carcinogenesis 0.44
Single-cell Transcriptomic Atlas of the Human Retina Identifies Cell Types Associated with Age-Related Macular Degeneration [Microfluidics] 0.44
Single cell RNA-seq resolves lineage-specific activation dynamics of human blood and tissue T cells 0.42
Genome-wide Circadian Control of Transcription at Active Enhancers Regulates Insulin Secretion and Diabetes Risk 0.42
Pancreatic Beta Cell Enhancers Regulate Rhythmic Transcription of Exocyst Triggering and Diabetes 0.42
RNA-seq of SCLC PDX models treated with EP 0.42
The LRF/ZBTB7A transcription factor is a BCL11A-independent repressor of fetal hemoglobin 0.42
Transcriptome analyses of iPSC-derived neural stem/progenitor cells and cerebral organoids from monozygotic twins discordant for schizoaffective bipolar disorder 0.42
A single cell reference map for human blood and tissue T cell activation 0.41
Transcriptome analysis of VCaP xenografts resistant to dual therapy with abiraterone and enzalutamide 0.41
Expression profiling by RNA-Seq of breast cancer samples from patients in walnut-consuming and control groups 0.41
GRO-seq from HCT116, MCF7 and SJSA cell lines treated with DMSO and Nutlin 0.39
Identification of a core p53 transcriptional program with highly fractionated tumor suppressive activity 0.39
The transcriptome of Kawasaki Disease arteritis 0.39
mRNA expression profile of Lymphocytes 0.39
Genome-wide Analysis of Chromatin Interactions in Human Cells 0.38
Effect of Polybrominated diphenyl ethers (PBDEs) on gene expression of MCF7 cells 0.38
ETS family proteins bind glucocorticoid receptor: relevance for treatment of Ewing sarcoma 0.38
Stranded RNA-seq were performed on total RNA following ribosomal RNAs depletion (Ribo-zero removal kit, illumina) for 3 brain , 8 IDHwt and 5 IDHmut glioma samples. 0.37
The transcriptomic landscape of MAIT cell development in the thymus (C006 RNAseq data set) 0.37
Human optic chiasm from healthy controls and multiple sclerosis patients 0.37
Transcriptome sequencing of a large human family identifies the impact of rare non-coding variants 0.37
Identification of expressed and conserved human non-coding RNAs 0.35
Deep RNA sequencing of the human placental transcriptome 0.33
Effects of Polybrominated Diphenyl Ether (PBDE) Mixture on estrogen receptor positive (ER+) patient-derived tumor xenograft (PDX) model 0.33
RNA Sequencing of Human iPS derived Cardiomyocytes 0.32
Whole blood stabilization for the microfluidic isolation and molecular characterization of circulating tumor cells 0.31
STX4 Over-Expression in Human islets 0.31
Gene expression analysis of human hepatocellular cancers 0.3
ChIPseq and RNAseq analysis of T47D cells with/without silencing TRPS1/CHD4 0.29
Maturing an Enteric Nervous System in Human Intestinal Organoid-derived Tissue-Engineered Small Intestine 0.27
siRNA-mediated knockdown 0.27
RNAseq of Breast cancer PDX samples 0.26
Analysis of transcrptomes of Danon patient derived hiPSC-cardiomyocytes by RNA-deep Sequencing 0.26
Neuroligin-4 Regulates Excitatory Synaptic Transmission in Human Neurons 0.25
Multiple waves of transcriptome changes during extended hypoxic induction in human pulmonary microvascular endothelial cells 0.24
Insulin induced alterations in chromatin acetylation and transcriptome in triple negative breast cancer cells 0.24
Hyper-excitability of Neurons generated from Patients with Bipolar Disorder 0.23
The ribosomal prolyl-hydroxylase OGFOD1 decreases during cardiac differentiation, modulates translation and spliceosomal processes 0.23
Human antimicrobial cytotoxic T lymphocytes, defined by NK receptors and antimicrobial proteins, kill intracellular bacteria 0.22
A single-cell atlas of the human cortex reveals drivers of transcriptional changes in Alzheimer’s disease in specific cell subpopulations 0.21
Gene expression profiles of PD1-high, PD1-intermediate, and PD1-negative tumor-infiltrating CD8 T cells in hepatocellular carcinoma 0.21
TNFα Signaling Exposes Latent Estrogen Receptor Binding Sites in Breast Cancer Cells 0.18
TNFα Signaling Exposes Latent Estrogen Receptor Binding Sites in Breast Cancer Cells [GRO-seq] 0.18
Gene expression of collecting duct carcinoma of the kidney 0.18
single cell RNA-seq from Purkinje cell (ENCSR888LYA) 0.13
RNA-sequencing of tamoxifen-resistant and -sensitive breast cancer cell lines. 0.13
Transcriptome analysis reveals differential splicing events in IPF lung tissue 0.12
RNA sequencing of prostate cancer and normal tissue from African Americans and European Americans 0.12
mRNA sequencing of the mouse and human Hep-Orgs, Chol-Orgs and primary hepatocytes 0.12
Bioreactor-engineered cancer tissues mimic phenotypes, gene expression profiles and drug resistance mechanisms detectable in xenografts and clinical specimens. 0.1
Influenza Vaccination Primes Human Myeloid Cell Cytokine Secretion and Natural Killer Cell Function 0.1
The gene expression profiles of gallbladder cancer 0.1
RNA sequencing based comparative analysis of human hepatic progenitor cells and their niche from alcoholic steatohepatitis livers 0.09
Interphase condensins regulate ligand-depedent enhancer activation 0.08
Interphase condensins regulate ligand-depedent enhancer activation (GRO-seq) 0.08
RNA sequencing of CACO-2 cells incubated with Bifidobacteria breve grown on human milk oligosaccharides. 0.07
Osmostress induced changes of chromatin architecture and transcription in mammalian cells 0.07
Osmostress induced changes of chromatin architecture and transcription in mammalian cells [RNA-Seq, HiC] 0.07
eRNA: A graphic user interface-based tool for RNA sequencing data analysis [mRNA-Seq] 0.07
eRNA: A graphic user interface-based tool for RNA sequencing data analysis 0.07
Cellular acidosis triggers MondoA transcriptional activity by driving mitochondrial ATP production 0.06
Gene expression profiles of active and restricted R/G-HIV+ primary human fetal astrocytes 0.05
Transcriptome of human ILC2s; primary vs IL-1b-primed 0.05
Genome-wide profiling of cervical RNA-binding proteins identified HPV regulation of RNASEH2A expression by viral E7 and E2F1 0.05
A large panel of isogenic APP and PSEN1 mutant human iPSC neurons reveals shared endosomal abnormalities mediated by APP b-CTFs, not Ab [RNA-seq] 0.04
Next Generation Sequencing identifying the dosage compensation state in human endometrial carcinoma and adjacent tissues 0.03
Unlocking the transcriptomic potential of formalin-fixed paraffin embedded clinical tissues: Comparison of gene expression profiling approaches 0.02
Unlocking the transcriptomic potential of formalin-fixed paraffin embedded clinical tissues: Comparison of gene expression profiling approaches [RNA-Seq] 0.02
Effect of Ro 08-2750 treatment on gene expression of human leukemia cell lines MOLM13 and K562 0.02
RNA-sequencing of formalin fixed human primary melanoma tissue 0.02
Dynamic gene expression in T-ALL following treatment and release of gamma-secretase inhibition [GRO-Seq] 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation